List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 997 studies with search of: hepatitis c
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
41 Completed Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated Interferon Alpha-2a and Ribavirin
42 Recruiting Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype I Infection
Condition: Chronic Hepatitis C
Intervention: Drug: CT-011
43 Completed Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3
Condition: Hepatitis C
Intervention: Drug: Peginterferon alfa-2a and ribavirin
44 Terminated Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206)(TERMINATED)
Conditions: Hepatitis C, Chronic;   Hepacivirus
Interventions: Biological: Peginterferon alfa-2b (SCH 54031);   Drug: Ribavirin (SCH 18908);   Behavioral: Patient assistance program
45 Active, not recruiting Fatty Liver in Chronic Hepatitis C (HCV): Is There a Difference in Oxidative Stress and Inflammation Compared to HCV Without Fatty Liver?
Conditions: Hepatitis C;   Steatosis or no Steatosis
Intervention:
46 Completed Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
Conditions: Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: thymalfasin (thymosin alpha 1) + PEGinterferon alfa-2a;   Drug: placebo + PEGinterferon alfa-2a
47 Completed Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides
Condition: Chronic Hepatitis C
Intervention: Biological: PEV2A PEV2B
48 Completed Combination Drug Therapy for Patients With Hepatitis C
Conditions: Chronic Hepatitis C;   Fibrosis;   Hemolytic Anemia
Intervention: Drug: Ribavirin
49 Completed A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 Infection
Condition: Hepatitis C, Chronic
Intervention: Drug: Celgosivir
50 Completed Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study)
Conditions: Hepatitis C;   Thalassemia
Interventions: Drug: Peginterferon Alfa-2a and Ribavirin;   Drug: Ribavirin
51 Completed Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection
Condition: Hepatitis C
Intervention: Biological: GI-5005
52 Completed Long-Term Therapy With Ribavirin for Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Ribavirin
53 Recruiting Pioglitazone in Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Pioglitazone
54 Completed History of Hepatitis C in Volunteer Blood Donors
Condition: Hepatitis C
Intervention:
55 Suspended Retreatment of Chronic Hepatitis C Non-Responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone
Condition: Chronic Hepatitis C
Interventions: Drug: Pioglitazone;   Drug: Increase response to interferon alpha plus ribavirin by increasing insulin sensitivity
56 Completed A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection
Conditions: HIV Infections;   Hepatitis C
Intervention:
57 Recruiting Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: pegylated interferon alpha and plus ribavirin
58 Recruiting Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection
Condition: Recurrent Hepatitis C
Interventions: Drug: Everolimus;   Drug: standard treatment
59 Completed TMC435350-TiDP16-C201 - OPERA 1: A Study of the Hepatitis C Virus (HCV) Protease Inhibitor TMC435350 or Placebo Administered With or Without the Standard of Care in Treatment Naive and Treatment Experienced Patients Infected With Genotype 1 Hepatitis C Virus.
Condition: Hepatitis C
Intervention: Drug: TMC435350, PegIFNa-2a, Ribavirin
60 Recruiting Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients
Condition: Hepatitis C
Intervention: Drug: ribavirin pre-treatment

Previous Page (21-40) Studies Shown (41-60) Next Page (61-80)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services